First Look Analyst Calls Briefing for Monday, October 31, 2022 

Source: seb_ra / iStock via Getty Images

This report was sent to Briefing.com subscribers earlier today.

Upgrades:

> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110

> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160

Downgrades:

> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman

> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60

> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James

> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James

Others:

> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13

> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.